8-K current report · filed Jun 5, 2026

Edgewise Therapeutics, Inc. (EWTX) 8-K Current Report: June 5, 2026

Short answer

Edgewise Therapeutics, Inc. (EWTX) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All three Class II director nominees elected through 2029, preserving board continuity.

Edgewise Therapeutics, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All three Class II director nominees elected through 2029, preserving board continuity
  • Jonathan Root received 59,213,781 votes for and 31,909,913 withheld, signaling notable shareholder reservations
  • KPMG LLP ratified as independent auditor for fiscal 2026 with 99,637,228 votes for
  • Executive compensation approved on advisory basis with 87,055,111 votes for, supporting current pay practices

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Edgewise Therapeutics, Inc. 8-K filings

Get the next EWTX 8-K as it lands

Follow EWTX for push alerts, or ask the research agent what this filing means.